About the Journal
Aims and Scope
Cardiology Plus (ISSN: 2470-7511) is an international, English-language, peer-reviewed, and open-access journal covering the field of cardiovascular medicine and related multidisciplinary fields. It is an official journal of the China Heart House (CHH) and Chinese Cardiovascular Association (CCA) and is published quarterly.
Cardiology Plus aims to publish high-quality research, including, but not limited to, technical advances in multidisciplinary therapy, biomarkers, imaging, physiology, pathology, and epidemiology in cardiovascular medicine. Contributions related to cardiovascular medicine also include basic science, nutrition, nursing, rehabilitation, public health, human genetics, environment, education, and sociology.
Cardiology plus is a professional exchange forum in the cardiovascular field. In addition to publishing original research on the latest development in Cardiology, editorial, review, meta-analysis, perspective, opinion, consensus and guideline, tutorial review, and letters from readers are also welcome.
Cardiology Plus is the Official Publication of
China Heart House (CHH) and Chinese Cardiovascular Association (CCA).
Introduction of the China Heart House (CHH) and the Chinese Cardiovascular Association (CCA)
Chinese Cardiovascular Association was founded on 28 December 2015, consisted by China Heart House (CHH, https://www.ccahouse.org) and Xinxin Heart (SIP) Foundation, based in Suzhou Industrial Park, proposed by a number of prominent cardiologists including Prof. Jun-Bo Ge and Prof. Yong Huo, instructed by Bureau of Medical Administration of National Health Commission of the People's Republic of China, and supported by Suzhou Industrial Park Administration Committee. With Cardiovascular Health of Every Chinese as mission, CCA takes root in professionalism, pushes forward progress and drives industry development in this field to boost Chinese cardiovascular prevention and control system on all fronts. In 2021, CCA became one of the four strategic partners of WHF to conduct in-depth international cooperation and jointly promote the global integrated development of cardiovascular disease prevention and treatment with the mission of enhancing international influences of Chinese cardiovascular industry.
Abstracting and Indexing Information
The journal is registered with the following abstracting partners: AI2, British Library, CCC, Deepdyve, EBSCO EDS, FiZ, GNM, Ingenta, Meta.Sciencescape, Naver, OCLC, ProQuest Summons, Ex-Libris, TDNet, Wanfang Data, CNKI (China National Knowledge Infrastructure), CNPIEC
This journal is indexed by SHERPA/Romeo (https://v2.sherpa.ac.uk/id/publication/41797), DOAJ, Ovid.
Email: [email protected]; [email protected]; [email protected]
Address: Pingjiang Pavilion, Gusuhui, No.36 Shuifang Road, Suzhou Industrial Park Suzhou 215000, Jiangsu, China.